Objectives Higher thyroid‐stimulating hormone (TSH) levels are associated with
differentiated thyroid cancers (DTC). To validate this association, we compared TSH levels …

Context: Thyroid stimulating hormone (TSH) is a known thyroid growth factor, but the
pathogenic role of TSH in thyroid oncogenesis is unclear. Objective: The aim was to …

Background The role of serum TSH concentrations as a predictor of malignancy of thyroid
nodule remains unclear. Objective To prospectively evaluate the usefulness of serum TSH …

Background It has previously been shown that higher serum TSH is associated with
increased thyroid cancer incidence and advanced‐stage disease. In the healthy adult …

There is mounting evidence that the serum concentration of TSH is an independent predictor
for the diagnosis of thyroid malignancy in patients with nodular thyroid disease. Furthermore …

Introduction: Several studies have shown an increased risk of thyroid malignancies in
patients with elevated TSH levels, even if these levels fell within the normal range. The aim …

Purpose Serum thyrotropin (TSH) is a well-established growth factor for thyroid nodules and
suppression of TSH concentrations by administering exogenous thyroxine may interfere with …

Context: TSH is a known thyroid growth factor, but the pathogenic role of TSH in thyroid
oncogenesis is unclear. Objective: The aim was to examine the relationship between …

Context: TSH is the main factor involved in the control of proliferation of thyrocytes. Recently,
a strong relationship between serum TSH and risk of thyroid malignancy has been reported …

Suppression therapy of thyreostimulin (TSH) using thyroid hormones improves survival of
subjects operated for differentiated thyroid cancer. The TSH level might be different …